Ito En Ltd
TSE:2593
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3 111
4 418
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Ito En Ltd
Current Assets | 243.9B |
Cash & Short-Term Investments | 101.7B |
Receivables | 68.8B |
Other Current Assets | 73.4B |
Non-Current Assets | 111.4B |
PP&E | 75.6B |
Intangibles | 6.7B |
Other Non-Current Assets | 29.1B |
Current Liabilities | 112.9B |
Accounts Payable | 32.6B |
Accrued Liabilities | 37.7B |
Other Current Liabilities | 42.5B |
Non-Current Liabilities | 59B |
Long-Term Debt | 44.2B |
Other Non-Current Liabilities | 14.9B |
Balance Sheet
Ito En Ltd
Apr-2015 | Apr-2016 | Apr-2017 | Apr-2018 | Apr-2019 | Apr-2020 | Apr-2021 | Apr-2022 | Apr-2023 | Apr-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
48 922
|
53 259
|
64 202
|
61 664
|
63 738
|
64 813
|
109 430
|
96 571
|
104 181
|
109 313
|
|
Cash Equivalents |
48 922
|
53 259
|
64 202
|
61 664
|
63 738
|
64 813
|
109 430
|
96 571
|
104 181
|
109 313
|
|
Total Receivables |
65 363
|
65 438
|
66 319
|
66 779
|
66 808
|
59 813
|
65 242
|
68 572
|
69 170
|
71 922
|
|
Accounts Receivables |
51 364
|
53 448
|
54 578
|
58 014
|
56 507
|
49 069
|
53 034
|
57 592
|
59 839
|
62 133
|
|
Other Receivables |
13 999
|
11 990
|
11 741
|
8 765
|
10 301
|
10 744
|
12 208
|
10 980
|
9 331
|
9 789
|
|
Inventory |
34 669
|
35 055
|
37 899
|
38 708
|
43 588
|
45 723
|
45 432
|
54 317
|
57 647
|
57 355
|
|
Other Current Assets |
4 643
|
5 765
|
6 237
|
3 687
|
3 315
|
3 617
|
3 776
|
3 818
|
3 395
|
5 159
|
|
Total Current Assets |
153 597
|
159 517
|
174 657
|
170 838
|
177 449
|
173 966
|
223 880
|
223 278
|
234 393
|
243 749
|
|
PP&E Net |
80 115
|
81 018
|
83 039
|
84 822
|
84 186
|
82 986
|
78 099
|
74 490
|
72 005
|
74 036
|
|
PP&E Gross |
80 115
|
81 018
|
83 039
|
84 822
|
84 186
|
82 986
|
78 099
|
74 490
|
72 005
|
74 036
|
|
Accumulated Depreciation |
66 587
|
66 329
|
79 473
|
85 938
|
89 359
|
90 832
|
90 287
|
88 263
|
88 969
|
93 949
|
|
Intangible Assets |
6 251
|
6 975
|
6 083
|
5 224
|
4 227
|
3 695
|
3 710
|
4 655
|
5 742
|
5 654
|
|
Goodwill |
27 791
|
20 179
|
18 371
|
16 364
|
14 729
|
7 875
|
4 625
|
3 594
|
2 528
|
1 456
|
|
Long-Term Investments |
5 940
|
5 764
|
6 245
|
7 599
|
6 563
|
5 085
|
6 217
|
5 154
|
6 311
|
7 581
|
|
Other Long-Term Assets |
12 253
|
14 249
|
14 010
|
16 320
|
16 827
|
17 044
|
16 534
|
17 188
|
17 795
|
21 416
|
|
Other Assets |
27 791
|
20 179
|
18 371
|
16 364
|
14 729
|
7 875
|
4 625
|
3 594
|
2 528
|
1 456
|
|
Total Assets |
285 947
N/A
|
287 702
+1%
|
302 405
+5%
|
301 167
0%
|
303 981
+1%
|
290 651
-4%
|
333 065
+15%
|
328 359
-1%
|
338 774
+3%
|
353 892
+4%
|
|
Liabilities | |||||||||||
Accounts Payable |
33 304
|
33 353
|
33 061
|
29 879
|
30 181
|
26 447
|
29 999
|
30 365
|
29 958
|
31 616
|
|
Accrued Liabilities |
24 116
|
26 478
|
28 846
|
29 376
|
29 209
|
27 414
|
28 401
|
30 561
|
33 815
|
36 273
|
|
Short-Term Debt |
600
|
620
|
620
|
620
|
620
|
1 220
|
1 520
|
1 485
|
1 430
|
920
|
|
Current Portion of Long-Term Debt |
11 458
|
31 623
|
10 739
|
8 402
|
6 451
|
9 579
|
26 450
|
3 783
|
13 448
|
15 204
|
|
Other Current Liabilities |
6 560
|
8 682
|
8 294
|
8 910
|
10 012
|
6 412
|
7 178
|
10 602
|
10 575
|
12 652
|
|
Total Current Liabilities |
76 038
|
100 756
|
81 560
|
77 187
|
76 473
|
71 072
|
93 548
|
76 796
|
89 226
|
96 665
|
|
Long-Term Debt |
70 549
|
46 283
|
70 901
|
66 204
|
61 972
|
54 878
|
70 881
|
73 116
|
61 872
|
59 878
|
|
Deferred Income Tax |
758
|
719
|
719
|
719
|
719
|
719
|
719
|
719
|
719
|
719
|
|
Minority Interest |
928
|
965
|
1 122
|
1 116
|
1 127
|
1 213
|
1 136
|
1 254
|
1 404
|
1 627
|
|
Other Liabilities |
10 841
|
12 729
|
12 516
|
13 307
|
13 894
|
14 287
|
14 860
|
14 716
|
14 829
|
13 414
|
|
Total Liabilities |
159 114
N/A
|
161 452
+1%
|
166 818
+3%
|
158 533
-5%
|
154 185
-3%
|
142 169
-8%
|
181 144
+27%
|
166 601
-8%
|
168 050
+1%
|
172 303
+3%
|
|
Equity | |||||||||||
Common Stock |
27 168
|
27 168
|
27 168
|
27 168
|
27 168
|
27 168
|
27 168
|
27 168
|
27 168
|
27 168
|
|
Retained Earnings |
90 959
|
94 350
|
102 816
|
110 163
|
119 375
|
122 015
|
123 827
|
131 222
|
138 961
|
149 258
|
|
Additional Paid In Capital |
13 003
|
11 384
|
11 388
|
11 389
|
11 385
|
11 390
|
11 404
|
11 406
|
11 302
|
11 298
|
|
Unrealized Security Profit/Loss |
4 063
|
0
|
3 920
|
3 102
|
3 774
|
4 821
|
4 097
|
4 851
|
4 360
|
4 204
|
|
Treasury Stock |
1 287
|
0
|
1 983
|
2 798
|
4 547
|
6 499
|
6 466
|
7 016
|
6 911
|
9 480
|
|
Other Equity |
1 053
|
1 125
|
118
|
186
|
189
|
771
|
85
|
3 829
|
4 564
|
7 549
|
|
Total Equity |
126 833
N/A
|
126 250
0%
|
135 587
+7%
|
142 634
+5%
|
149 796
+5%
|
148 482
-1%
|
151 921
+2%
|
161 758
+6%
|
170 724
+6%
|
181 589
+6%
|
|
Total Liabilities & Equity |
285 947
N/A
|
287 702
+1%
|
302 405
+5%
|
301 167
0%
|
303 981
+1%
|
290 651
-4%
|
333 065
+15%
|
328 359
-1%
|
338 774
+3%
|
353 892
+4%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
123
|
123
|
122
|
122
|
122
|
121
|
121
|
121
|
121
|
120
|